- ... Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary ...
- ... Malnutrition Medicines including amphotericin, antibodies targeting the epidermal growth factor (EGF) receptor, cisplatin, cyclosporine, diuretics, proton pump inhibitors, tacrolimus, and aminoglycoside ...
- ... plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin, as evidenced by the NCT00924144 phase III ... Trials of other chemotherapy ...
- ... Brien T, Bradburn M, et al. Vascular endothelial growth factor is a predictor of relapse and stage ... receiving cisplatin or carboplatin. Scand Audiol. 1999; 28 (3):139– ...
- ... intake of alcohol are less likely to experience cisplatin-induced N&V.[ 4 ] Age. ... invasion or growth in the gastrointestinal tract, liver, or central nervous ...
- ... ciprofloxacin was the commonest choice of antibiotic. Prophylactic growth factors – primary prophylaxis It was reported that growth factors ( ... preparation for the majority of their regimens. Prophylactic growth factors – secondary prophylaxis Growth factors were used for secondary ...
- ... pathways to an extent similar to tumor necrosis factor-alpha (TNF-alpha).[ 40 ] Furthermore, ... drug cisplatin .[ 5 , 27 , 34 , 41 ] All the aspects of ...
- NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ...Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., 1999... QY 410 Platelet Transforming Growth Factor see Transforming Growth Factor beta ... see Cisplatin Platybasia WE 730 Platyhelminths QX 350-422 Platyrrhina ...
- ... tw. 10 or/7-9 11 Receptor, Epidermal Growth Factor/ use ppez 12 epidermal growth factor receptor/ use emez 13 (epidermal growth factor or egf receptor or (growth factor adj3 receptor) ...
- ... protein kinase inhibitor$”).ti,ab. 70 (“vascular endothelial growth factor$” adj2 inhibitor$).ti,ab. 71 “Poly(ADP-ribose) ... inhibitor$).ti,ab. 80 (“EGFR inhibitor$” or “epidermal growth factor inhibitor$” or “epidermal growth factor receptor inhibitor$”).ti, ...
84 results